ProfileGDS5822 / ILMN_1229777
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 74% 68% 69% 70% 73% 75% 75% 77% 79% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 172.374
GSM1276600PDAC Late Ablation Control 247.668
GSM1276601PDAC Late Ablation Control 364.769
GSM1276602PDAC Late Ablation 146.570
GSM1276603PDAC Late Ablation 272.973
GSM1276604PDAC Late Ablation 395.575
GSM1303940PDAC Late Ablation_anti-CTLA4 180.575
GSM1303941PDAC Late Ablation_anti-CTLA4 2130.677
GSM1303942PDAC Late Ablation_anti-CTLA4 3163.879